Systemic effects of topical application of beclomethasone 17,21-dipropionate: comparative studies with betamethasone 17-valerate ointment and fluocinonide cream.
D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000368:Aged; D001507:Beclomethasone / Q000008:administration & dosage* / Q000627:therapeutic use; D001623:Betamethasone / Q000031:analogs & derivatives*; D001624:Betamethasone Valerate / Q000008:administration & dosage* / Q000627:therapeutic use; D005260:Female; D005446:Fluocinolone Acetonide / Q000031:analogs & derivatives*; D005447:Fluocinonide / Q000008:administration & dosage* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D009824:Ointments; D011565:Psoriasis / Q000188:drug therapy*
D009824:Ointments; D005446:Fluocinolone Acetonide; D005447:Fluocinonide; D001623:Betamethasone; D001624:Betamethasone Valerate; D001507:Beclomethasone